default author photo

Raffaello Verardi

National Institutes of Health - Vaccine Research Center

Bethesda, MD 20892-9806

United States

SCHOLARLY PAPERS

3

DOWNLOADS

100

TOTAL CITATIONS

2

Scholarly Papers (3)

1.

Structure of Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition

Number of pages: 43 Posted: 05 Aug 2019
National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Health Laboratory Services (NHLS) - Centre for HIV and STIs, University of the Witwatersrand, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center and National Institutes of Health - Vaccine Research Center
Downloads 40 (1,183,237)
Citation 1

Abstract:

Loading...

broadly neutralizing antibody, HIV-1 envelope trimer, multidonor antibody class, PCT64, PG9, PGDM1400, PGT145, tyrosine sulfation, V1V2-apex recognition

2.

Anti-V2 Antibodies Virus Vulnerability Revealed by Envelope V1 Deletion in HIV Vaccine Candidates

Number of pages: 87 Posted: 21 Oct 2020
National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Immune Biology of Retroviral Infection Section, National Institutes of Health (NIH) - Section on Intercellular Interactions, Advanced Bioscience Laboratories, Advanced Bioscience Laboratories, New York University (NYU) - NYU Langone Health, New York University (NYU) - NYU Langone Health, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Institutes of Health (NIH) - Laboratory of Immunoregulation, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Duke University - Division of Surgical Sciences, Duke University - Division of Surgical Sciences, National Institutes of Health (NIH) - Structural Biology Section, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - ImmunoTechnology Section, National Institutes of Health (NIH) - ImmunoTechnology Section, National Institutes of Health (NIH) - ImmunoTechnology Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, Duke University - Department of Surgery, Duke University - Division of Surgical Sciences, Duke University - Medical Center, Duke University - Duke Human Vaccine Institute, National Cancer Institute at Frederick - Human Retrovirus Section, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, National Cancer Institute at Frederick - Human Retrovirus Section, National Cancer Institute - Biostatistics and Data Management Section, Frederick National Laboratory - AIDS and Cancer Virus Program, Frederick National Laboratory - AIDS and Cancer Virus Program, Frederick National Laboratory - AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research - AIDS and Cancer Virus Program, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Institutes of Health (NIH) - Laboratory of Immunoregulation, Duke University - Division of Surgical Sciences, National Institutes of Health (NIH) - Section on Intercellular Interactions, National Cancer Institute - Immune Biology of Retroviral Infection Section, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - ImmunoTechnology Section, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, New York University (NYU) - NYU Langone Health and Medical University of Bialystok - Centre for Bioinformatics and Data Analysis
Downloads 33 (1,277,121)

Abstract:

Loading...

HIV, SIV, V1/V2, V1, ALVAC

3.

A Structure-Based Matrix Approach Yields Improved VRC01-Class Antibodies for HIV-1 Therapy and Prevention

Number of pages: 41 Posted: 05 Oct 2020
National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, Independent, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Viral Pathogenesis Section, National Institutes of Health - Vaccine Research Center and National Institutes of Health - Vaccine Research Center
Downloads 27 (1,359,097)
Citation 1

Abstract:

Loading...

antibody VRC01, broadly neutralizing antibody, HIV-1 envelope trimer, polyreactivity, prophylaxis, treatment